Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating expenses:    
Research and development $ 9,286 $ 7,457
General and administrative 3,762 3,021
Total operating expenses 13,048 10,478
Loss from operations (13,048) (10,478)
Interest income 54 466
Net loss $ (12,994) $ (10,012)
Net loss per common share, basic and diluted $ (0.25) $ (0.30)
Weighted-average shares used to compute net loss per common share, basic and diluted 51,058,039 32,867,597